News Search

Search results for:

Ondine presents ground-breaking findings in the fight against multidrug-resistant pathogens at 19th World Congress of the International Photodynamic Association

Ondine presents ground-breaking findings in the fight against multidrug-resistant pathogens at 19th World Congress of the International Photodynamic Association Photodisinfection shown to enhance the potency of many antibiotics, including vancomycin, ciprofloxacin, and tetracycline, as well as antiseptics such as benzalkonium chloride and chlorhexidine. Combination of traditional antibiotics and photodynamic [...]

UCL Shows Steriwave Effective Against Mucor Fungus

  UCL Shows Steriwave Effective Against Mucor Fungus  UCL Researchers Present Steriwave Photodisinfection Efficacy Against Dangerous Mucor Fungus at 19th World Congress of the International Photodynamic Association in Shanghai, China   Mucor fungal infections pose a serious risk to immunocompromised patients, such as those undergoing bone marrow transplants, with [...]

Steriwave in all British Columbia Health Authorities

Vancouver, British Columbia, Canada - August 23, 2024 Ondine Biomedical Inc. (LON: OBI), a leading provider of light-activated antimicrobial technology to prevent and treat hospital infections, is pleased to announce that Steriwave® nasal decolonization is now being used in all five of British Columbia's health [...]

Leeds Teaching Hospitals NHS Trust to use Steriwave

Vancouver, British Columbia, Canada - August 6, 2024 Ondine Biomedical Inc. (LON: OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments, and Iskus Health announce that Leeds Teaching Hospitals NHS Trust will begin using its Steriwave® nasal decolonization technology later this month. Leeds Teaching [...]

Steriwave now available through NHS Supply Chain

Vancouver, British Columbia, Canada - June 21, 2024 Ondine Biomedical Inc. (LON: OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments, is pleased to announce that its Steriwave® nasal photodisinfection is now available through the NHS Supply Chain, making it significantly easier for NHS [...]

ECDC report shows HAIs are increasing antibiotic use

A third of microorganisms causing healthcare-associated infections were found to be resistant to antibiotics, leaving doctors with fewer effective treatment options for patients Vancouver, British Columbia, Canada - May 10, 2024 A recent report from the European Centre for Disease Prevention and Control (ECDC) helps underscore [...]

New study confirms nose is key source of infection

Findings include 86% of surgical site infections caused by bacteria from the patients’ own nose, skin, or gut and nearly 60% of infections are resistant to antibiotics Vancouver, British Columbia, Canada - April 25, 2024 Ondine Biomedical Inc. (LON: OBI), the Canadian life sciences company [...]

Corporate and Trading Update

Significant revenue growth and commercial momentum Vancouver, British Columbia, Canada - April 24, 2024 Ondine Biomedical (LON: OBI), a leading provider of light-activated antimicrobial technology to treat and prevent hospital infections, provides an update on its recent developments, strategic priorities and 2024 corporate plans. Commercial [...]

Steriwave in first Australian hospital

Mater Hospital, North Sydney has become the first Australian hospital to use Ondine Biomedical’s award-winning light-activated antimicrobial technology Vancouver, British Columbia, Canada - April 22, 2024 Ondine Biomedical Inc. (LON: OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments, announces that Mater Hospital, North [...]

32% Fewer SSIs After Steriwave Replaced Mupirocin

New data shows reduced cardiac infections and significant cost savings after the light-activated antimicrobial, Steriwave, replaced the antibiotic standard of care at the Mazankowski Alberta Heart Institute Vancouver, British Columbia, Canada - April 15, 2024 Ondine Biomedical Inc. (LON: OBI), the Canadian life sciences company [...]

For Media Information

Simon Vane Percy

Amanda Bernard

Go to Top